Global Plantar Fasciitis Treatment Market, By Type (Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Intracorporeal Pneumatic Shockwave Therapy and Others), Treatment Type (Pharmacological Treatment, Orthotic Devices, Shockwave Therapy, Surgery, and Other Treatment Types), End-User (Hospitals, Clinics, Others) – Industry Trends and Forecast to 2030.
Plantar Fasciitis Treatment Market Analysis and Size
According to an April 2021 update from the National Safety Council (NSC) in America, the Consumer Product Safety Commission (CPSC) reports that visits to emergency departments during the first seven months of the COVID-19 pandemic for consumer product-related injuries decreased by 24%. Track and field injuries had the most significant decrease in injuries. From March to September 2020, hockey, soccer, baseball, football, and basketball saw a more than 60% drop. According to the CPSC, these significant decreases were caused by the suspension of school and youth sports leagues in the spring and summer months of 2020 in response to the pandemic. These developments influenced global demand for plantar fasciitis treatment.
Data Bridge Market Research analyses that the plantar fasciitis treatment market which is USD 1371.91 million in 2022, is expected to reach USD 7094.37 million by 2030, at a CAGR of 22.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Plantar Fasciitis Treatment Market Scope and Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Type (Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Intracorporeal Pneumatic Shockwave Therapy and Others), Treatment Type (Pharmacological Treatment, Orthotic Devices, Shockwave Therapy, Surgery, and Other Treatment Types), End-User (Hospitals, Clinics, Others)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
Market Players Covered
|
Bayer AG (Germany), SUPERFEET WORLDWIDE, LLC (U.S.), Bauerfeind USA Inc. (Germany), Ottobock (Germany), Recover Sports Medicine (Australia), Shapecrunch (India), 3M (U.S.), OrthoBethesda (U.S.), Apothecary Products, LLC (U.S.), Ellis & Badenhausen (U.S.), SYNXSOLE PTY LTD. (Australia) and Revance Therapeutics, (U.S.)
|
Market Opportunities
|
|
Market Definition
Plantar fasciitis is one of the most common causes of injuries to the foot. The condition is caused by the sole's tenderness and affects the foot's heel portion. It is defined as a type of sole muscle inflammation that is common in people who must stand for long periods of time on hard surfaces.
Plantar Fasciitis Treatment Market Dynamics
Drivers
- Rise in cases of injuries
According to data from the Centers for Disease Control and Prevention (CDC) updated in January 2022, unintentional injury accounted for 200,995 deaths in 2020, while traffic accidents killed 40,698 people in the same year. According to the same data, there were 24.8 million physician visits and 97.9 million emergency department visits in the United States in 2020. Thus, a high number of cases of various injuries indicates a greater number of people suffering from plantar fasciitis, driving the global market's growth.
- Rise in geriatric population
According to World Population Prospects 2022, the proportion of the global population aged 65 and up is expected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of people aged 65 and up is expected to be more than double that of children under the age of five, and roughly equal to that of children under the age of twelve. As a result of the growing geriatric population suffering from musculoskeletal diseases such as plantar fasciitis, the demand for orthotic devices is expected to rise over the forecast period.
Opportunities
- Rise in obesity
Obesity and weight issues are well-known problems in modern societies worldwide, according to data updated in 2022 by the Organization for Economic Cooperation and Development (OECD). Obesity affected approximately 42% of all African American adults in 2020, compared to 36% of Hispanics and 13% of Asian/Pacific Islanders. That same year, Mississippi was reported to have the highest obesity rate of any state in the United States, with an incredible 40% of adults in Mississippi self-reporting obesity. Colorado, Massachusetts, and Hawaii are among the states with the lowest obesity rates. Thus, the region's high obesity rate is expected to increase the number of cases of plantar fasciitis in the United States, causing the market to expand.
Restraints/Challenges
- High cost
Price fluctuations in raw materials used in the manufacture of effective therapeutic medical devices are expected to stymie market growth. Concerns about the products' declining profitability ratio are expected to pose a challenge to the plantar fasciitis treatment market during the forecast period of 2023-2030.
This plantar fasciitis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the plantar fasciitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Aetrex, Inc. announced the launch of its Foot.com Data Portal, a dedicated platform to assist shoe manufacturers around the world in creating better-fitting footwear.
- In 2020, Aetrex launched its thinnest 3D printed orthotic, designed specifically for shoes without removable insoles.
Global Plantar Fasciitis Treatment Market Scope
The plantar fasciitis treatment market is segmented on the basis of type, treatment type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Medication Therapy
- Oral
- Parenteral
- Orthotics
- Shockwave Therapy
- Surgery
- Intracorporeal Pneumatic Shockwave Therapy
- Others
Treatment Type
- Pharmacological Treatment
- Orthotic Devices
- Shockwave Therapy
- Surgery
- Other Treatment Types
End-User
- Hospitals
- Clinics
- Others
Plantar Fasciitis Treatment Market Regional Analysis/Insights
The plantar fasciitis treatment market is analyzed and market size insights and trends are provided by country, type, treatment type and end-user as referenced above.
The countries covered in the plantar fasciitis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the plantar fasciitis treatment market because of the region's large patient pool and middle-class population.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the rise in the number of obese people in the United States.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The plantar fasciitis treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for plantar fasciitis treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the plantar fasciitis treatment market. The data is available for historic period 2011-2021
Competitive Landscape and Plantar Fasciitis Treatment Market Share Analysis
The plantar fasciitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to plantar fasciitis treatment market.
Some of the major players operating in the plantar fasciitis treatment market are:
- Bayer AG (Germany)
- SUPERFEET WORLDWIDE, LLC (U.S.)
- Bauerfeind USA Inc. (Germany)
- Ottobock (Germany)
- Recover Sports Medicine (Australia)
- Shapecrunch (India)
- 3M (U.S.)
- OrthoBethesda (U.S.)
- Apothecary Products, LLC (U.S.)
- Ellis & Badenhausen (U.S.)
- SYNXSOLE PTY LTD. (Australia)
- Revance Therapeutics, (U.S.)
SKU-